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ABSTRACT   
Background: While the prevalence of asthma in children is decreasing or remaining the 
same, time-trends in the prevalence of rhinitis in children are not known. Understanding 
sensitisation trends may help inform about trends in asthma and rhinitis prevalence.  
Objective: To assess time -trends of wheeze, rhinitis and aero-allergen sensitisation 
prevalence at 10 years of age we compared two birth cohorts established 12 years apart. To 
gain insight into differences in disease prevalence we assessed association of family-history, 
early life exposures and sensitisation with wheeze and rhinitis in each cohort. 
Methods: The IoW (Isle-of-Wight) and FAIR (Food-Allergy-and-Intolerance-Research) 
unselected birth cohorts were established in 1989 and 2001 in IoW. Identical ISAAC 
questionnaire and Skin Prick test data were collected and compared at 10 years of age. 
Results: Over the 12 year period from 2001 to 2012, prevalence of lifetime-wheeze, current-
wheeze, and those ever-treated-for-asthma decreased by 15.9% (45.5-vs-29.6,p<0.001), 3.9% 
(18.9-vs-15, p=0.020) and 8.2% (31.7-vs-23.5, p=0.001) respectively. Conversely, current-
rhinitis and lifetime-rhinitis prevalence increased by 5.5% (22.6-vs-28.1, p=0.004) and 13% 
(18.6-vs-31.7, p<0.001) respectively. Atopic status remained stable, however house dust mite 
(HDM) sensitisation decreased by 5.6% (19.2-vs-13.6, p=0.004) and grass sensitisation 
increased by 3.5% (12.9-vs-16.4, p=0.054). Male-sex, parental history of asthma and HDM 
sensitisation were significantly associated with lifetime-wheeze in both cohorts while 
maternal smoking during pregnancy was a significant risk factor only in the earlier IoW-
cohort. Parental history of rhinitis and grass sensitisation were significantly associated with 
lifetime-rhinitis in both cohorts while HDM sensitisation was significant only for the IoW-
cohort. 
Conclusion: Contrasting changes were noted with falling wheeze and HDM sensitisation but 
rising rhinitis and grass sensitisation prevalence. Changing prevalence of aero-allergen 
sensitisations may explain the different time trends observed in these cohorts. 
Key words: Time trends in UK, Asthma prevalence, allergic rhinitis, Hay fever prevalence, 
Sensitisation Prevalence 
Abbreviations: IoW; Isle of Wight, FAIR; Food Allergy and Intolerance Research   
INTRODUCTION   
Asthma is the most common chronic disease affecting children [1] and rhinitis remains a 
significant health problem affecting quality of life[2]. There is global variation in asthma 
prevalence, with the point prevalence being higher in more affluent regions compared to less 
affluent regions [3, 4]. Globally asthma and rhinitis prevalence increased in the latter part of 
the 20
th
 Century[5]. However global time trend studies in the last decade, showed that while 
childhood asthma prevalence continued to increase in less affluent regions with a low point 
prevalence, it was reaching a plateau in more affluent regions with higher point prevalence 
[6]. The United Kingdom (UK) has one of the highest asthma prevalence globally [4]. In UK, 
asthma and rhinitis prevalence increased from the 1970`s to mid-1990`s [5, 7]. However, time 
trends in asthma prevalence during the first decade of the 21
st
 century are unclear, with some 
studies showing increase and others showing plateauing or decrease in asthma prevalence in 
schoolchildren [7-11].  
It has been challenging to identify mechanisms driving changes in prevalence of allergic 
airway disease [12].Asthma is a complex disease where interaction of genetics and 
environment play an important role [13].  The temporal changes in asthma prevalence are too 
quick to be explained by naturally occurring genetic alterations in populations [6]. Allergic 
sensitisation to aero-allergens plays an important role; house dust mite (HDM) sensitisation is 
strongly associated with asthma [14-16]. Recent European studies of time trends in asthma 
prevalence have found that similar to asthma prevalence, aeroallergen sensitisation has 
remained stable from 1991 to 2001-02 in schoolchildren [17, 18]. Similarly allergic 
sensitisation is a strong risk factor for rhinitis [19] and it is known that grass pollen 
sensitisation is associated with rhinitis in the UK [20]. 
Meaningful analyses of time trends in changing prevalence of allergic disease require 
studies employing the same methodology and in the same geographical location over time. 
Arshad et al have shown that HDM sensitisation is an important risk factor for asthma  with 
an odds ratio of 8.07 (4.60–14.14) and sensitisation to grass was found to be an important risk 
factor for rhinitis with an odds ratio of 5.02 (2.21–11.41).  We have previously reported the 
prevalence of current wheeze in the Isle of Wight (IoW) birth cohort at 10 years as 18.9% in 
1999-2000 with associations to allergic sensitisation and sex [16].  We hypothesize that (i) 
the prevalence of wheeze and rhinitis will increase over a 12 year period and (ii) the increase 
in wheeze and rhinitis will be associated with a change in the same direction for house dust 
mite and grass pollen sensitisation respectively. Trends in prevalence of wheeze and rhinitis 
in UK have been reported till 2005; this paper looks at the continued trends till 2012 and also 
looks at time trends of aero-allergen sensitisations which have not been reported before in 
UK population. To investigate this, we compared current wheeze, lifetime wheeze, ever 
treated for asthma, current rhinitis symptoms, lifetime rhinitis and prevalence of allergic 
sensitisation to common aeroallergens at 10 years of age in two unselected population based 
birth cohorts established 12 years apart in the same county, the Isle of Wight, UK. Results in 
this paper are based on data of follow ups at 10 years of age of the IoW birth cohort [21] 
(1999-2000) and Food Allergy and Intolerance Research (FAIR) birth cohort [22] (2011-12). 
METHODS 
Study Population/Birth cohorts: 
This is a repeat cross-sectional study performed in two separate cohorts of children aged 10 
years, resident in the same locality and separated by 12 years. The Isle-of-Wight birth cohort 
(IoW-cohort) is a population based birth cohort established in 1989/90 for prospective study 
of asthma and allergic diseases. Children born between January 1989 and February 1990 on 
the Isle of Wight were recruited at birth (N=1536). Children have been reviewed at 1, 2, 4, 10 
and 18 years[23]. The ten year follow up was done between 1999 and 2000. Food allergy and 
intolerance research (FAIR) is another population based birth cohort (N=969) established on 
the Isle of Wight in 2001/02 for prospective study of allergic diseases [22]. Children were 
seen at 1, 2, 3 [24] and 10 year. The 10 year follow up was completed between 2011 and 
2012. Table I gives a general description of both cohorts at their 10 year follow ups. Ethics 
approval was obtained at each follow-ups for both cohorts by local research ethics 
committees (FAIR: 10/H0504/11, IoW: No. 18/98), and informed consent was obtained from 
parents, and assent from participants.  
 
Questionnaires: 
ISAAC (International Study of Asthma and Allergies in childhood) and study specific 
questionnaires were used in both studies. Prevalence rates are based on parental responses to 
ISAAC questionnaires [25] used at 10 year follow ups in both cohorts. Lifetime wheeze 
symptoms were based on response to “Has your child ever had wheezing or whistling in the 
chest at any time in the past?” current wheeze was based on “Has your child had wheezing or 
whistling in the chest in the last 12 months?” and ever treated for asthma was based on “Has 
your child been treated for asthma?” Current rhinitis symptoms and lifetime rhinitis were 
derived from the responses to “In the past 12 months, has your child had a problem with 
sneezing, or a runny or blocked nose when he/she did not have a cold or the flu?” and “Has 
your child ever had hay fever?” respectively. Risk factors; family history of asthma or 
rhinitis, prenatal smoking and pet exposures were prospectively collected.  
Sensitisation: 
Allergic sensitisation was defined by positive Skin Prick Test (SPT) indicated by a wheal size 
of 3 mm or more than the negative control (Saline). Sensitisation to aero-allergens that were 
tested in both studies were compared; HDM (Dermatophagoides pteronyssinus ), Cat (Felis 
domesticus) and Grass (mixed  grasses) pollen. SPT was done using standardised allergen 
reagents and methodology (ALK-Abell_o, Hørsholm, Denmark)[16, 22] and by the same 
research team. 
Statistical Analysis: 
The prevalence of wheeze, rhinitis and allergen sensitisation are given in proportions with 
95% confidence intervals (95% CI). The significance of difference in prevalence between the 
two cohorts was tested using chi-square tests. Logistic regression analyses (Univariate and 
multivariate) were used to test the association of sex, family history, prenatal exposures and 
aero-allergen sensitisation with prevalence of wheeze and rhinitis. Backward stepwise model 
was used for multivariate regression analysis. All the analyses were done using SPSS Version 
19 (IBM, Chicago, USA). CIA (Confidence Interval Analysis software) was used for 95% CI 
for proportions and the difference in prevalence. P value of less than 0.05 was considered 
significant. 
RESULTS 
Study population: 
Of the 1456 children available for follow up in the IoW-cohort, 1373 (94%) provided 
questionnaire based information and 1036 (71%) underwent SPT at 10 years of age in 1999-
2000. In the FAIR follow up at 10 years of age in 2011-12, 827 (85%) out of 969 available 
children responded to the questionnaire based information and 588 (61%) underwent SPT. 
Characteristics of the cohorts are displayed in Table I. The subsets who underwent SPT in 
both cohorts were representative of the respective cohorts (Supplementary Table E1).  
 Trend in Prevalence of wheeze, rhinitis and sensitisation 
Prevalence of lifetime wheeze, current wheeze and ever treated asthma all decreased 
significantly from 1999-2000 to 2011-12. Conversely current rhinitis symptoms and lifetime 
rhinitis both increased significantly between these two time points (Table II). 
Changes in prevalence for individual aero-allergen sensitisation varied according to allergen 
(Table III). HDM sensitisation decreased significantly, while grass pollen sensitisation 
increased (not significant) and cat sensitisation remained unchanged during the same period. 
There was no difference in time trends of wheeze and rhinitis prevalence between IoW and 
FAIR cohorts when stratified by sex (Supplementary Table E2).  The only difference noticed 
was in the increase in grass sensitisation from IoW to FAIR-cohort which was higher in girls 
compared to boys. Interactions of sex by cohorts were not significant for both lifetime 
wheeze and rhinitis (Supplementary Table E3). 
Family history and prenatal risk factors 
Overall, parental history of asthma was significantly higher in the FAIR-cohort compared to 
the IoW-cohort by 5.2% (p=0.012), which was significant for maternal (4.6%, p=0.009) but 
not paternal (2.5%, p=0.118) history. However sibling history of asthma significantly 
decreased by 5.1% (p=0.017). Parental history of rhinitis significantly increased from by 
14.1% (p<0.001), which was significant for both maternal and paternal history of rhinitis. 
Sibling history of rhinitis showed non-significant increase of 1.7% (p=0.349). Maternal 
smoking during pregnancy showed a drop by 2.8% comparing the two time points but this 
was not significant and there was no difference in prenatal pet exposure in the two cohorts 
(Table IV). 
Association of sex, family history and prenatal factors and aero-allergen sensitisation to 
wheeze and rhinitis 
 
Lifetime prevalence of wheeze:  
Male sex, parental history, sibling history, prenatal smoke exposure, HDM, grass and cat 
sensitisation were associated with wheeze in both cohorts in univariate analysis. Using 
backward stepwise multivariate logisitic regression male sex (p=0.038), parental history 
(p<0.001), sibling history (p=0.008), maternal smoking during pregnancy (p=0.018) and 
HDM sensitisation (p<0.001) remained independently significant in the IoW-cohort while sex 
(p=0.007), parental history (p<0.001) and HDM sensitisation (p=0.004) remained 
independently significant in the FAIR-cohort (Table V). Therefore sex, parental history and 
HDM sensitisation were the common factors significantly associated with lifetime wheeze in 
both cohorts.  
Lifetime prevalence of rhinitis:  
Parental history and sensitisations to HDM, cat and grass were associated with lifetime 
rhinitis in both cohorts. Sibling history and prenatal maternal smoking in IoW and prenatal 
pet exposure in the FAIR-cohort were also associated with lifetime rhinitis using a univariate 
regression analysis. Using a multivariate regression with backward stepwise analysis, 
parental history (p<0.001), HDM (P<0.001) and grass (p<0.001) sensitisation remained 
significant in the IoW-cohort whereas only parental history of rhinitis (p<0.001) and grass 
sensitisation (p<0.001) remained significant in the FAIR-cohort (Table VI). Thus parental 
history of rhinitis and sensitisation to grass were common factors significantly associated 
with lifetime rhinitis in both cohorts. 
Risk factors; HDM sensitisation and parental history of asthma for lifetime wheeze and grass 
sensitisation and parental history of rhinitis for lifetime rhinitis were tested for interaction 
with cohorts. Only cohort and parental history of asthma was significant (p=0.045) and all 
other interaction terms were not significant as summarised in supplementary table E4. 
DISCUSSION 
This study; comparing upper and lower airway disease symptom prevalence at 10 years of 
age in two population based birth cohorts 12 years apart in the same location has shown 
falling prevalence of current and lifetime wheeze plus ever being treated for asthma, 
associated with HDM sensitisation which decreased during the same period. By contrast in 
the same period from 1999-2000 to 2011-12, there was an increase in current and lifetime 
rhinitis prevalence, which was associated with grass sensitisation which increased during the 
same period. Male sex, parental history of asthma and HDM sensitisation for wheeze and 
parental history of rhinitis and grass sensitisation remained significant risk factors in both 
cohorts for asthma and rhinitis respectively. Maternal smoking in pregnancy was significantly 
associated with lifetime wheeze only in the earlier IOW-cohort. 
Time trend analysis can be challenging due to a number of factors including lack of 
uniformity in methodology and definitions of outcomes. We used identical validated 
questions (ISAAC) and the same methodology [25] which makes prevalence in our 2 cohorts 
comparable. Moreover, both cohorts in this study are population based, from the same 
geographical location and assessed by the same research team thus restricting the plausible 
biases and the influence of environmental differences when comparing the prevalence from 
wider geographical regions. Both cohorts have shown high follow up rates and the risk of 
significant bias is relatively low,. Other important aero-allergens like tree pollen and common 
moulds are missing in this study which can be one of the limitations of this paper, but the 
three aero-allergens studied usually explain majority of the atopic status[26]. Another 
potential limitation is the generalizability of the prevalence rates estimated on the IoW. 
Although, it remains a theoretical possibility, the population on the IoW is neither socially, 
not geographically, isolated. The prevalence rates for allergic diseases we have reported 
previously are very similar to the developed world in general and UK in particular [16]. 
Therefore, the time trends seen in our cohorts should be broadly generalizable.  Also results 
from other islands have been comparable to the reference region on the mainland [27].  
Anderson et al looked at ISAAC study results  from UK centres from 1995 to 2002 in 12-14 
year old UK children and reported an increase in ‘lifetime asthma’ (from 20.6% to 25.9%), 
but decrease in current wheeze (from 33.9% to 27.5%)[9]. In the Aberdeen Schools Asthma 
Survey of 9-12 years old children, Malik et al assessed the time trends at three time points 
(1999, 2004 and 2009).  Current wheeze (in the past 3 years) steadily decreased from 1999 to 
2009 (27.9% in 1999, 25.2% in 2004,  22.2% in 2009), whilst ‘lifetime asthma’ prevalence 
showed temporal increase (from 24.3% to 28.4%) between 1999 to 2004 and then decreased 
from 2004 to 2009 (22.1%)[28].  Our results in similar age children (10 years old) confirm 
the continued decrease in prevalence of wheeze in the UK till 2012. The decrease in current 
and lifetime wheeze prevalence in our study is further substantiated by a concurrent fall in the 
prevalence of ever treated for asthma. In contrast to wheeze prevalence, we observed a 
significant rise in the prevalence of current rhinitis symptoms and lifetime rhinitis. Similar 
increasing trends for rhinitis have been reported in the UK looking at the primary care 
datasets from 2001 to 2005[29], however the Aberdeen schools asthma survey also showed a 
temporal increase in prevalence of ‘ lifetime rhinitis’ from 1999 to 2004 (15.4% to 26.5%) 
but not much change between 2004 to 2009 (25.7%)[11].   
As reported by Zollner et al in Germany and Braun-Fahrlander et al in Switzerland, we also 
found stable overall aero-allergen sensitisation on the Isle of Wight. However both studies 
reported mixed inhalant screen and differences in individual aero-allergen sensitisation were 
not investigated [17, 18]. We report a significant decrease in HDM sensitisation by 5.6% and 
a non-significant increase in grass sensitisation by 3.5%. In the Isle of Wight prevention 
study (different cohort from the 2 cohorts compared in this paper), reduction in the level of 
HDM mite was associated with reduced level of allergic sensitisation to HDM [30]. Based on 
this finding, it might be that falling HDM exposure levels may have contributed to the falling 
HDM sensitisation observed in our study. However, without HDM exposure information at 
two time points, this remains purely speculative but an important area for future research.  
Allergic conditions are complex diseases where multiple environmental exposures, hereditary 
factors and gene-environment interactions play important roles [13]. One of the criticism for 
this paper would be not looking at all the plausible factors like decreasing birth rate, changes 
in family sizes, changes in living conditions and respiratory viral infections[12, 31]. Parental 
history is a known risk factor for developing allergic airway diseases [32, 33] and prenatal 
smoke exposure is associated with the development of asthma [33]. Prenatal smoke exposure 
declined which could be due to a better awareness of harmful effects of smoking particularly 
during pregnancy, and the association analysis suggested declining effect of prenatal smoke 
exposure on wheeze and rhinitis between these two cohorts. Parental history remained 
significantly associated to wheeze and rhinitis in both cohorts. We have shown that the 
prevalence of wheeze decreased in the current generation (in the cohort studied) and the 
sibling history of asthma also decreased, whereas the parental history of asthma increased 
between the two cohorts, suggesting different time trends in prevalence in two generations. 
Mothers of IoW-cohort, date of birth ranges from 1941 to 1973 (mean 1962) and for mothers 
of FAIR from 1956 to 1986 (mean 1973). It is plausible that the increase in the parent 
generation reflects increase in asthma prevalence observed in the latter half of 20
th
 century.  
HDM sensitisation is associated with lifetime wheeze and sensitisation to grass with lifetime 
rhinitis in both cohorts. Li et al. show  that asthma prevalence continues to increase 
predominantly in HDM sensitised urban Chinese children[34]. An association does not 
necessarily imply causality; however one interpretation of our results is of a possible role of 
decreasing HDM and increasing grass sensitisations driving the contrasting time trends of 
wheeze and rhinitis prevalence respectively. Recently a synergistic effect of family history 
and second hand smoking has been shown for adult onset asthma [35]. There is a possibility 
of synergic effect of decreasing HDM sensitisation, decreasing prenatal smoke exposure and 
family history of asthma on decreasing wheeze prevalence and this provides an area for 
further research. We did observe a decrease in the maternal smoking during pregnancy from 
IoW to FAIR-cohort but this change was not significant, so the interpretations have to be 
made with caution. 
In conclusion, this is the first study reporting contrasting time trends for childhood allergic 
airway diseases along with aeroallergen sensitisations in the same geographical location; 
falling wheeze and rising rhinitis associated with falling time trends of HDM sensitisation 
with rise in grass pollen sensitisation.  Changing associations with aero-allergen sensitisation 
and smoke exposure partly contribute to changing prevalence of wheeze and rhinitis. 
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Table I: Descriptions of IoW and FAIR cohorts and 10 year follow up rates. 
 IoW cohort FAIR cohort 
Birth year 1989-1990 2001-2002 
Recruited at birth 1456 969 
Male : Female 53% : 47% 51% : 49% 
Period of 10 year FU 1999-2000 2011 - 2012 
Questionnaire completed  
at 10 year 
1373 (94%) 827 (85%) 
SPT  done at 10 year 1036 (71%) 588 (61%) 
FU - Follow up, SPT- Skin Prick Test, IoW- Isle of Wight, FAIR-Food Allergy and Intolerance Research 
 
  
Table II: Time trends in wheeze, asthma and rhinitis prevalence.  
Characteristic IoW 
1999-2000 
% (95% CI) 
n/N 
FAIR 
2011-12 
% (95% CI)  
n/N 
Difference 
 % 
(95% CI) 
p value 
Lifetime Wheeze  
 
45.5% 
(42.9 to 48.2) 
625/1373 
 
 
29.6% 
(26.6 to 32.8) 
245/828 
 
-15.9 
(-19.9 to -11.8) 
<0.001 
Current Wheeze  
 
18.9% 
(16.9 to 21.0) 
259/1373 
 
 
15% 
(12.7 to 17.6) 
124/827 
 
-3.9 
(-7 to -0.6) 
0.020 
Ever treated for 
asthma  
 
31.7% 
(29.2 to 34.3) 
402/1267 
 
 
23.5% 
(20.1 to 27.4) 
120/510 
-8.2 
(-12.5 to -3.6) 
0.001 
Current rhinitis  
 
 
22.6% 
(20.5 to 24.9) 
308/1362 
 
 
 
28.1% 
(25.1 to 31.2) 
232/826 
 
 
5.5 
(1.7 to 9.3) 
 
0.004 
Lifetime rhinitis  
 
18.6% 
(16.7 to 20.8) 
256/1373 
 
31.7% 
(26.9 to 36.8) 
107/338 
 
13.0 
(7.8 to 18.5) 
<0.001 
n; proportion with feature, N; total number with responses to question 
 
 
 
 
  
Table III: Time trends in prevalence of aero-allergen sensitisation 
Aero-allergens IoW 
1999-2000 
% (95% CI)  
n/N 
FAIR 
2011-2012 
% (95% CI) 
n/N 
Difference  
% 
(95% CI) 
p value 
HDM  
 
19.2 
(16.9 to 21.7) 
199/1035 
 
 
13.6 
(11.1 to 16.6) 
80/587 
 
-5.6 
(-9.2 to -1.8) 
0.004 
Cat  
  
 
7.9 
(6.4 to 9.7) 
82/1035 
 
7.7 
(5.8-10.1) 
45/586 
 
-0.2 
(-2.9 to 2.6) 
0.861 
Grass  
 
12.9 
(11.0 to 15.1) 
134/1036 
 
16.4 
(13.6 to 19.6) 
96/585 
 
3.5 
(-0.1 to7.2) 
0.054 
Any aeroallergen  
 
25.7 
(23.1 to 28.4) 
266/1035 
 
24.1 
(20.8 to 27.7) 
141/587 
 
-1.6 
(-5.9 to 2.8) 
0.512 
n; number of positive SPT to the allergen, N; total number tested for the allergen 
 
 
 
  
Table IV: Prevalence of family history and prenatal exposures in both cohorts 
(irrespective of asthma or rhinitis in children) 
Factor IoW 1999-2000 
% (95% CI)  
n/N 
FAIR 2011-12 
% (95% CI)  
n/N 
Difference  
% 
(95% CI) 
p value 
Mother Hx of asthma  
 
17.7 
(15.7 to 19.8) 
233/1317 
22.3 
(19.6 to 25.3) 
184/825 
+4.6 
(1.2 to 8.2) 
0.009 
Father Hx of Asthma  
 
13.9 
(12.1 to 15.9) 
183/1317 
16.4 
(14.0 to 19.1) 
132/806 
+2.5 
(-0.6 to 5.7) 
0.118 
Parental Hx of Asthma  
 
30.4 
(28.0 to 33.0) 
401/1317 
35.7 
(32.5 to 39.0) 
289/810 
+5.3 
(1.1 to 9.4) 
0.012 
Sibling Hx of Asthma  
 
31.4 
(29.0 to 34.0) 
414/1318 
26.4 
(23.3 to 29.7) 
190/721 
-5.0 
(-9.1 to -0.9) 
0.017 
Mother Hx of Rhinitis  
 
24.3 
(22.0 to 26.7) 
320/1318 
33.9 
(30.8 to 37.2) 
280/825 
+9.6 
(5.7 to 13.6) 
<0.001 
Father Hx of Rhinitis  
 
16.4 
(14.5 to 18.5) 
216/1316 
25.1 
(22.2 to 28.2) 
202/804 
+8.7 
(5.2 to 12.4) 
<0.001 
Parental Hx of Rhinitis  
 
37.1 
(34.5 to 39.7) 
489/1318 
51.2 
(47.7 to 54.6) 
415/811 
+14.1 
(9.7 to 18.4) 
<0.001 
Sibling Hx of Rhinitis  
 
19.3 
(17.3 to 21.6) 
255/1318 
21.1 
(18.3 to 24.2) 
152/721 
+1.8 
(-1.9 to 5.5) 
0.349 
Mother smoked during 
pregnancy 
 
25.2 
(23.1 to 27.5) 
384/1521 
22.4 
(19.9 to 25.2) 
210/937 
-2.8 
(-6.2 to 0.7) 
0.111 
Any pet during 
pregnancy 
  
 
50.4 
(47.9 to 52.9) 
765/1517 
50.4 
(47.2 to 53.5) 
488/969 
0 
(-4.1 to 4.0) 
0.974 
 IoW Cohort  (1999-2000) FAIR Cohort   (2011-2012) 
 % Univariate Multivariate  Univariate Multivariate 
 n/N OR (95% 
CI) 
p OR (95% 
CI) 
p % OR (95% 
CI) 
p OR (95% 
CI) 
p 
 Lifetime  Wheeze 
Male sex 50.2 
350/697 
1.47 
(1.19-1.82) 
<0.001 1.32 
(1.02-1.72) 
0.038 32.9 
140/425 
 
1.39 
(1.03-1.88) 
0.030 1.81 
(1.18-2.45) 
0.007 
HDM 
Sensitisation 
67.8 
135/199 
 
2.76 
(1.99-3.83) 
<0.001 2.28 
(1.58-3.31) 
<0.001 56.3 
45/80 
 
3.84 
(2.36-6.23) 
<0.001 2.61 
(1.36-5.03) 
 
0.004 
Grass 
Sensitisation 
63.4 
85/134 
 
2.06 
(1.42-3.00) 
<0.001 - NS 41.7 
40/95 
 
1.95 
(1.24-3.06) 
0.004 - NS 
Cat 
Sensitisation 
68.3 
56/82 
 
2.50 
(1.54-4.05) 
<0.001 1.93 
(1.08-3.44) 
0.026 50.0 
22/44 
 
2.631 
(1.42-4.89) 
0.002 - NS 
Parental History 59.1 
237/401 
2.21 
(1.74-2.81) 
<0.001 2.00 
(1.51-2.65) 
<0.001 45.8 
132/288 
3.31 
(2.42-4.54) 
<0.001 2.82 
(1.83-4.36) 
<0.001 
Sibling history 54.1 
224/414 
1.66 
(1.32-2.10) 
<0.001 1.47 
(1.11-1.96) 
0.008 41.1 
78/190 
2.08 
(1.47-2.95) 
<0.001 - NS 
Pet during 
pregnancy 
45.5 
317/697 
1.01 
(0.81-1.25) 
0.944 - NS 28.1 
121/430 
0.87 
(0.64-1.17) 
0.342 - NS 
Maternal smoking* 52.7 
168/319 
1.46 
(1.14-1.88) 
0.003 1.47 
(1.11-1.96) 
0.018 35.7 
60/168 
1.44 
(1.00-2.06) 
0.049 - NS 
Table V: Logistic regression analyses for association of Sex, aero-allergen sensitisations, heredity and prenatal exposures with lifetime wheeze  
Multivariate; backward stepwise model. % -proportion of the characteristic with wheeze (n/N), OR; Odds Ratio, 95% CI; 95% confidence interval, HDM; House dust mite. * 
Mother smoking during pregnancy.  
  IoW  Cohort (1999-2000) FAIR  Cohort  (2011-2012) 
  Univariate Multivariate  Univariate Multivariate 
 % OR (95% CI) p OR (95% CI) p % OR (95% CI) p OR (95% CI) p 
Lifetime   rhinitis 
Male Sex 
 
18.8 
131/697 
 
1.020 
(0.78-1.34) 
0.885 - NS 34.8 
64/184 
 
1.38 
(0.87-2.19) 
0.178 - NS 
HDM 
Sensitisation 
44.2 
88/199 
4.55 
(3.25-6.39) 
<0.001 2.17 
(1.42-3.32) 
<0.001 60.6 
40/66 
 
4.83 
(2.74-8.51) 
<0.001 - NS 
Grass 
Sensitisation 
 
64.9 
87/134 
 
11.51 
(7.70-17.20) 
<0.001 
 
7.66 
(4.79-12.26) 
<0.001 77.6 
66/85 
 
18.79 
(10.17-34.73) 
<0.001 15.89 
(7.711-32.76) 
<0.001 
Cat 
Sensitisation 
 
56.1 
46/82 
 
6.06 
(3.80-9.67) 
<0.001 - NS 75.7 
28/37 
 
8.93 
(4.03-19.76) 
<0.001 - NS 
Parental History 26.8 
131/489 
2.32 
(1.75-3.07) 
<0.001 1.91 
(1.34-2.73) 
<0.001 44.0 
85/193 
4.72 
(2.72-8.20) 
<0.001 4.21 
(2.01-8.80) 
<0.001 
Sibling history 25.5 
65/255 
1.69 
(1.22-2.34) 
0.002 - NS 45.9 
28/61 
1.26 
(0.71-2.23) 
0.428 - NS 
Pet during pregnancy 17.5 
122/697 
0.86 
(0.66-1.13) 
0.290 - NS 26.2 
45/172 
0.59 
(0.37-0.94) 
0.028 - NS 
Maternal smoking* 14.1 
45/319 
1.52 
(1.07-2.15) 
0.020 - NS 28.1 
18/64 
0.81 
(0.45-1.49) 
0.502 - NS 
Table VI : Logistic regression analysis for association of Sex, aero-allergen sensitisations, heredity and prenatal exposures with lifetime rhinitis 
 
Multivariate; backward stepwise model. % -proportion of the characteristic with rhinitis, OR; Odds Ratio, 95% CI; 95% confidence interval, HDM; House dust mite. * Mother 
smoking during pregnancy 
 
1. WHO. Asthma. 2012 [October 2012]; Available from: 
http://www.who.int/mediacentre/factsheets/fs307/en/index.html. 
2. Canonica GW, Bousquet J, Mullol J, Scadding GK, Virchow JC. A survey of the burden of 
allergic rhinitis in Europe. Allergy. 2007;62 Suppl 85:17-25. Epub 2007/12/06. 
3. Lai CK, Beasley R, Crane J, Foliaki S, Shah J, Weiland S, et al. Global variation in the 
prevalence and severity of asthma symptoms: phase three of the International Study of Asthma 
and Allergies in Childhood (ISAAC). Thorax. 2009;64(6):476-83. Epub 2009/02/25. 
4. ISAACSteeringCommittee. Worldwide variation in prevalence of symptoms of asthma, 
allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and 
Allergies in Childhood (ISAAC) Steering Committee. Lancet. 1998;351(9111):1225-32. Epub 
1998/06/27. 
5. Burr ML, Butland BK, King S, Vaughan-Williams E. Changes in asthma prevalence: two 
surveys 15 years apart. Arch Dis Child. 1989;64(10):1452-6. Epub 1989/10/01. 
6. Asher MI, Montefort S, Björkstén B, Lai CKW, Strachan DP, Weiland SK, et al. Worldwide 
time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in 
childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. The Lancet. 
2006;368(9537):733-43. 
7. Gupta R, Sheikh A, Strachan DP, Anderson HR. Time trends in allergic disorders in the UK. 
Thorax. 2007;62(1):91-6. Epub 2006/09/05. 
8. Burr ML, Wat D, Evans C, Dunstan FD, Doull IJ, British Thoracic Society Research C. Asthma 
prevalence in 1973, 1988 and 2003. Thorax. 2006;61(4):296-9. Epub 2006/01/07. 
9. Anderson HR, Ruggles R, Strachan DP, Austin JB, Burr M, Jeffs D, et al. Trends in prevalence 
of symptoms of asthma, hay fever, and eczema in 12-14 year olds in the British Isles, 1995-2002: 
questionnaire survey. Bmj. 2004;328(7447):1052-3. Epub 2004/03/19. 
10. Shamssain M. Trends in the prevalence and severity of asthma, rhinitis and atopic eczema 
in 6- to 7- and 13- to 14-yr-old children from the north-east of England. Pediatric allergy and 
immunology : official publication of the European Society of Pediatric Allergy and Immunology. 
2007;18(2):149-53. Epub 2007/03/07. 
11. Malik G, Tagiyeva N, Aucott L, McNeill G, Turner SW. Changing trends in asthma in 9-12 
year olds between 1964 and 2009. Arch Dis Child. 2011;96(3):227-31. Epub 2010/11/12. 
12. Butland BK, Strachan DP, Lewis S, Bynner J, Butler N, Britton J. Investigation into the 
increase in hay fever and eczema at age 16 observed between the 1958 and 1970 British birth 
cohorts. Bmj. 1997;315(7110):717-21. Epub 1997/10/07. 
13. Su MW, Tung KY, Liang PH, Tsai CH, Kuo NW, Lee YL. Gene-gene and gene-environmental 
interactions of childhood asthma: a multifactor dimension reduction approach. PloS one. 
2012;7(2):e30694. Epub 2012/02/23. 
14. Lau S, Illi S, Sommerfeld C, Niggemann B, Bergmann R, von Mutius E, et al. Early exposure 
to house-dust mite and cat allergens and development of childhood asthma: a cohort study. The 
Lancet. 2000;356(9239):1392-7. 
15. Arshad SH, Tariq SM, Matthews S, Hakim E. Sensitization to common allergens and its 
association with allergic disorders at age 4 years: A whole population birth cohort study. 
Pediatrics. 2001;108(2):art. no.-e33. 
16. Kurukulaaratchy RJ, Fenn M, Twiselton R, Matthews S, Arshad SH. The prevalence of 
asthma and wheezing illnesses amongst 10-year-old schoolchildren. Respir Med. 2002;96(3):163-9. 
Epub 2002/03/22. 
17. Zollner IK, Weiland SK, Piechotowski I, Gabrio T, von Mutius E, Link B, et al. No increase in 
the prevalence of asthma, allergies, and atopic sensitisation among children in Germany: 1992-
2001. Thorax. 2005;60(7):545-8. Epub 2005/07/05. 
18. Braun-Fahrlander C, Gassner M, Grize L, Takken-Sahli K, Neu U, Stricker T, et al. No further 
increase in asthma, hay fever and atopic sensitisation in adolescents living in Switzerland. The 
European respiratory journal : official journal of the European Society for Clinical Respiratory 
Physiology. 2004;23(3):407-13. Epub 2004/04/07. 
19. Kurukulaaratchy RJ, Karmaus W, Arshad SH. Sex and atopy influences on the natural 
history of rhinitis. Current opinion in allergy and clinical immunology. 2012;12(1):7-12. Epub 
2011/12/14. 
20. Arshad SH, Karmaus W, Matthews S, Mealy B, Dean T, Frischer T, et al. Association of 
allergy-related symptoms with sensitisation to common allergens in an adult European 
population. Journal of investigational allergology & clinical immunology : official organ of the 
International Association of Asthmology. 2001;11(2):94-102. Epub 2001/10/20. 
21. Arshad SH, Hide DW. Effect of environmental factors on the development of allergic 
disorders in infancy. The Journal of allergy and clinical immunology. 1992;90(2):235-41. Epub 
1992/08/01. 
22. Dean T, Venter C, Pereira B, Arshad SH, Grundy J, Clayton CB, et al. Patterns of 
sensitization to food and aeroallergens in the first 3 years of life. The Journal of allergy and clinical 
immunology. 2007;120(5):1166-71. Epub 2007/09/11. 
23. Raza A KR, Grundy JD, Clayton CB, Mitchell FA, Roberts G, Ewart S, Sadeghnejad A, Arshad 
SH. What does adolescent undiagnosed wheeze represent? Findings from the Isle of Wight Cohort. 
Eur Respir J. 2012;Sep;40(3):. Epub Epub 2012 Jan 20. 
24. Venter C, Pereira B, Voigt K, Grundy J, Clayton CB, Higgins B, et al. Prevalence and 
cumulative incidence of food hypersensitivity in the first 3 years of life. Allergy. 2008;63(3):354-9. 
Epub 2007/12/07. 
25. Lukrafka JL, Fuchs SC, Moreira LB, Picon RV, Fischer GB, Fuchs FD. Performance of the 
ISAAC questionnaire to establish the prevalence of asthma in adolescents: a population-based 
study. The Journal of asthma : official journal of the Association for the Care of Asthma. 
2010;47(2):166-9. Epub 2010/02/23. 
26. Arshad SH, Tariq SM, Matthews S, Hakim E. Sensitization to common allergens and its 
association with allergic disorders at age 4 years: a whole population birth cohort study. 
Pediatrics. 2001;108(2):E33. Epub 2001/08/03. 
27. Jeffs D, Grainger R, Powell P. Is childhood allergy more common amongst an island 
population? The journal of the Royal Society for the Promotion of Health. 2000;120(4):236-41. 
Epub 2001/02/24. 
28. Panickar JR, Dodd SR, Smyth RL, Couriel JM. Trends in deaths from respiratory illness in 
children in England and Wales from 1968 to 2000. Thorax. 2005;60(12):1035-8. Epub 2005/09/07. 
29. Ghouri N, Hippisley-Cox J, Newton J, Sheikh A. Trends in the epidemiology and prescribing 
of medication for allergic rhinitis in England. J R Soc Med. 2008;101(9):466-72. Epub 2008/09/10. 
30. Scott M, Roberts G, Kurukulaaratchy RJ, Matthews S, Nove A, Arshad SH. Multifaceted 
allergen avoidance during infancy reduces asthma during childhood with the effect persisting until 
age 18 years. Thorax. 2012;67(12):1046-51. Epub 2012/08/04. 
31. Urquhart DS, Anderson AK, McKenzie SA. Fewer colds, less asthma? A hypothesis to 
explain the fall in childhood asthma in the UK. Journal of epidemiology and community health. 
2008;62(10):921-5. Epub 2008/09/16. 
32. Arshad SH, Karmaus W, Raza A, Kurukulaaratchy RJ, Matthews SM, Holloway JW, et al. The 
effect of parental allergy on childhood allergic diseases depends on the sex of the child. The 
Journal of allergy and clinical immunology. 2012;130(2):427-34 e6. Epub 2012/05/23. 
33. Kurukulaaratchy RJ, Matthews S, Waterhouse L, Arshad SH. Factors influencing symptom 
expression in children with bronchial hyperresponsiveness at 10 years of age. The Journal of 
allergy and clinical immunology. 2003;112(2):311-6. Epub 2003/08/05. 
34. Li J, Wang H, Chen Y, Zheng J, Wong GWK, Zhong N. House dust mite sensitization is the 
main risk factor for the increase in prevalence of wheeze in 13- to 14-year-old schoolchildren in 
Guangzhou city, China. Clinical & Experimental Allergy. 2013;43(10):1171-9. 
35. Lajunen TK, Jaakkola JJ, Jaakkola MS. The synergistic effect of heredity and exposure to 
second-hand smoke on adult-onset asthma. American journal of respiratory and critical care 
medicine. 2013;188(7):776-82. Epub 2013/08/29. 
 
Supplementary information  
 
Table (supplementary E1): Description of the subset with SPT and the whole cohorts. 
 
 IoW  1999 - 2000 FAIR 2011 - 2012 
 
Subset with 
SPT 
Whole 
Cohort 
p 
Subset with 
SPT 
Whole 
Cohort 
p 
Sex; Boys 
 
49.8 
(515/1035) 
 
51.2 
(786/1536) 
0.494 
52.3 
(308/589) 
51.0 
(494/950) 
0.916 
Parental history 
of asthma 
3 
2.9 
(323/981) 
 
30.4 
(401/1317) 
0.220 
36.0 
(207/575) 
35.7 
(289/810) 
0.910 
Parental history 
of rhinitis 
 
39.5 
(388/982) 
 
37.8 
(489/1318) 
0.242 
55.0 
(317/576) 
51.2 
(415/811) 
0.156 
Current wheeze 
 
20.7 
(214/1035) 
 
18.9 
(259/1373) 
0.277 
15.4 
(91/589) 
15.0 
(124/829) 
0.822 
Current 
hayfever 
25.9 
(268/1035) 
22.6 
(308/1362) 
0.067 
31.9 
(187/587) 
28.1 
(232/826) 
0.140 
 
 
 
  
Table (supplementary E2): Prevalence of wheeze, rhinitis and sensitisation by sex 
 
 Boys  Girls  
 
IoW 
1999-2000 
FAIR 
2011-12 
p value 
IoW 
1999-2000 
FAIR 
2011-12 
p value 
Lifetime wheeze 
50.2 
(350/697) 
 
32.9 
(140/425) 
 
<0.001 
40.7 
275/676 
 
26.1 
(105/403) 
 
<0.001 
Current wheeze 
21.5 
(150/697) 
 
17.2 
(73/425) 
 
0.077 
16.1 
(109/676) 
 
12.7 
(51/402) 
 
0.125 
Current rhinitis 
22.7 
(157/692) 
 
28.1 
(119/424) 
 
0.043 
22.5 
(151/670) 
 
28.1 
(113/402) 
 
0.040 
Lifetime rhinitis 
18.8 
(131/697) 
 
34.8 
(64/184) 
 
<0.001 
18.5 
(125/676) 
 
27.9 
(43/154) 
 
0.009 
HDM Sensitisation 
22.5 
116/515 
 
16.9 
52/307 
 
0.055 
16.0 
83/520 
 
10.0 
28/280 
 
0.020 
Grass 
Sensitisation 
16.3 
84/516 
 
18.4 
56/305 
 
0.443 
9.6 
50/520 
 
14.3 
40/280 
 
0.046 
Cat 
Sensitisation 
8.0% 
41/515 
 
8.8% 
27/306 
 
0.665 
7.9% 
41/520 
 
6.4% 
18/280 
 
0.452 
 
 
Table E3: Sex by cohort interaction effects on lifetime wheeze and rhinitis.  
 
Lifetime Wheeze 
 OR (95%CI) P 
Cohort 0.52 (0.40 – 0.67) <0.001 
Gender 1.47 (1.19 – 1.82) <0.001 
Cohort*Gender 0.95 (0.66 – 1.37) 0.776 
Lifetime Rhinitis 
Cohort 1.71 (1.14 – 2.55) 0.009 
Gender 1.02 (0.78 – 1.34) 0.885 
Cohort*Gender 1.35 (0.79 -2.31) 0.275 
 
 
 
 
 
 
 
Supplementary Table E4: Interactions of risk factors and cohorts for lifetime wheeze 
and rhinitis.   
Lifetime wheeze 
HDM sensitisation OR (95%CI) P 
Cohort (FAIR) 0.44 (0.34 – 0.56) <0.001 
HDM (Positive) 2.76 (1.99 – 3.83) <0.001 
Cohort*HDM 1.39 (0.77 – 2.50) 0.271 
Parental asthma 
Cohort 0.39 (0.30 – 0.50) <0.001 
Parental Asthma 2.21 (1.74 – 2.81) <0.001 
Cohort* Parental Asthma 1.50 (1.01 -2.23) 0.045 
Lifetime rhinitis 
Grass sensitisation OR (95%CI) p 
Cohort (FAIR) 1.15 (0.78 – 1.70) 0.486 
Grass (Positive) 11.51 (7.70 – 17.20) <0.001 
Cohort*Grass 1.63 (0.78 – 3.40) 0.190 
Parental Rhinitis 
Cohort 1.77 (1.27 – 2.47) 0.001 
Parental Rhinitis 1.69 (1.22 – 2.34) 0.002 
Cohort* Parental Rhinitis 1.40 (0.72 – 2.73) 0.323 
 
 
